Advertisement
Screener

Johnson & Johnson (JNJ) Debt / Equity

Johnson & Johnson (JNJ) Debt / Equity

  • 2026-06-28: Debt/Equity Ratio 0.58.
  • 2026-03-29: Debt/Equity Ratio 0.68.
  • 2025-12-28: Debt/Equity Ratio 0.51.
  • 2025-09-28: Debt/Equity Ratio 0.58.

Complete source-backed debt/equity ratio history.

Available history
2008-12-28 to 2026-06-28
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2026-06-280.58
2026-03-290.68
2025-12-280.51
2025-09-280.58
2025-06-290.65
2025-03-300.67
2024-12-290.45
2024-09-290.51
2024-06-300.58
2024-03-310.48
2023-12-310.4
2023-10-010.42
2023-07-020.61
2023-04-020.75
2023-01-010.37
2022-10-020.43
2022-07-030.43
2022-04-030.44
2022-01-020.43
2021-10-030.48
2021-07-040.48
2021-04-040.51
2021-01-030.54
2020-09-270.59
2020-06-280.48
2020-03-290.45
2019-12-290.47
2019-09-290.5
2019-06-300.48
2019-03-310.5
2018-12-300.51
2018-09-300.48
2018-07-010.51
2018-04-010.51
2017-12-310.53
2017-10-010.48
2017-07-020.48
2017-04-020.46
2017-01-010.34
2016-10-020.37
2016-07-030.36
2016-04-030.32
2016-01-030.28
2015-09-270.28
2015-06-280.27
2015-03-290.28
2014-12-280.27
2014-09-280.2
2014-06-290.22
2014-03-300.23
2013-12-290.25
2013-09-290.22
2013-06-300.22
2013-03-310.24
2012-12-300.25
2012-09-300.26
2012-07-010.29
2012-04-010.32
2012-01-010.34
2011-10-020.3
2011-07-030.3
2011-04-030.3
2011-01-020.16
2010-10-030.21
2010-07-040.22
2010-04-040.23
2010-01-030.16
2009-09-270.23
2009-06-280.29
2008-12-280.28

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2025-12-280.51
2024-12-290.45
2023-12-310.4
2023-01-010.37
2022-01-020.43
2021-01-030.54
2019-12-290.47
2018-12-300.51
2017-12-310.53
2017-01-010.34
2016-01-030.28
2014-12-280.27
2013-12-290.25
2012-12-300.25
2012-01-010.34
2011-01-020.16
2010-01-030.16
2008-12-280.28

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ELI LILLY & Co (LLY)United States$1,113.804B42.28
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38